Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Toru Utsunomiya is active.

Publication


Featured researches published by Toru Utsunomiya.


Hepato-gastroenterology | 2012

The beneficial effects of Kampo medicine Dai-ken-chu-to after hepatic resection: a prospective randomized control study.

Masaaki Nishi; Mitsuo Shimada; Hideaki Uchiyama; Toru Ikegami; Yusuke Arakawa; Jun Hanaoka; Hirohumi Kanemura; Yuji Morine; Satoru Imura; Hidenori Miyake; Toru Utsunomiya

BACKGROUND/AIMS After hepatic resection, delayed flatus and impaired bowel movement often cause problematic postoperative ileus. Kampo medicine, Dai-kenchu-to (DKT), is reported to have a various beneficial effects on bowel systems. The aim of this study was to prospectively evaluate effects of DKT after hepatic resection. METHODOLOGY Thirty-two patients who underwent hepatic resection between July 2007 and August 2008 in Tokushima University Hospital were prospectively divided into DKT group (n=16) and control group (n=16). In DKT group, 2.5 g of DKT was administered orally three times a day from postoperative day (POD) 1. Blood was examined on POD 1, 3, 5 and 7. Postoperative first flatus, bowel movement and full recovery of oral intake, hospital stays and complications were checked. RESULTS In DKT group, levels of c-reactive protein and beta-(1-3)-D-glucan on POD 3 were significantly decreased (p<0.05). Moreover, postoperative periods for the first flatus, bowel movement and the full recovery of oral intake were significantly shortened in DKT group (p<0.05). CONCLUSIONS DKT suppressed inflammatory reaction, stimulated bowel movement and improved oral intake after hepatic resection, which may decrease serious morbidity after hepatic resection.


Medical Physics | 2013

Blood vessel‐based liver segmentation using the portal phase of an abdominal CT dataset

Ahmed S. Maklad; Mikio Matsuhiro; Hidenobu Suzuki; Yoshiki Kawata; Noboru Niki; Mitsuo Satake; Noriyuki Moriyama; Toru Utsunomiya; Mitsuo Shimada

PURPOSE Blood vessel (BV) information can be used to guide body organ segmentation on computed tomography (CT) imaging. The proposed method uses abdominal BVs (ABVs) to segment the liver through the portal phase of an abdominal CT dataset. This method aims to address the wide variability in liver shape and size, separate liver from other organs of similar intensity, and segment hepatic low-intensity tumors (LITs). METHODS Thin ABVs are enhanced using three-dimensional (3D) opening. ABVs are extracted and classified into hepatic BVs (HBVs) and nonhepatic BVs (non-HBVs) with a small number of interactions, and HBVs and non-HBVs are used for constraining automatic liver segmentation. HBVs are used to individually segment the core region of the liver. To separate the liver from other organs, this core region and non-HBVs are used to construct an initial 3D boundary surface. To segment LITs, the core region is classified into non-LIT- and LIT-parts by fitting the histogram of the core region using a variational Bayesian Gaussian mixture model. Each part of the core region is extended based on its corresponding component of the mixture, and extension is completed when it reaches a variation in intensity or the constructed boundary surface, which is reconfirmed to fit robustly between the liver and neighboring organs of similar intensity. A solid-angle technique is used to refine main BVs at the entrances to the inferior vena cava and the portal vein. RESULTS The proposed method was applied to 80 datasets: 30 Medical Image Computing and Computer Assisted Intervention (MICCAI) and 50 non-MICCAI; 30 datasets of non-MICCAI data include tumors. Our results for MICCAI-test data were evaluated by sliver07 (http://www.sliver07.org/) organizers with an overall score of 85.7, which ranks best on the site as of July 2013. These results (average ± standard deviation) include the five error measures of the 2007 MICCAI workshop for liver segmentation as follows. Results for volume overlap error, relative volume difference, average symmetric surface distance, root mean square symmetric surface distance, and maximum symmetric surface distance were 4.33 ± 0.73, 0.28 ± 0.87, 0.63 ± 0.16, 1.19 ± 0.28, and 14.01 ± 2.88, respectively; and when applying our method to non-MICCAI data, results were 3.21 ± 0.75, 0.06 ± 1.29, 0.45 ± 0.17, 0.98 ± 0.26, and 12.69 ± 3.89, respectively. These results demonstrate high performance of the method when applied to different CT datasets. CONCLUSIONS BVs can be used to address the wide variability in liver shape and size, as BVs provide unique details for the structure of each studied liver. Constructing a boundary surface using HBVs and non-HBVs can separate liver from its neighboring organs of similar intensity. By fitting the histogram of the core region using a variational Bayesian Gaussian mixture model, LITs are segmented and measuring the volumetry of non-LIT- and LIT-parts becomes possible. Further examination of the proposed method on a large number of datasets is required for clinical applications, and development of the method for full automation may be possible and useful in the clinic.


Hepatology Research | 2014

Beneficial effects of enteral nutrition containing with hydrolyzed whey peptide on warm ischemia/reperfusion injury in the rat liver

Jun Hanaoka; Mitsuo Shimada; Toru Utsunomiya; Yuji Morine; Satoru Imura; Tetsuya Ikemoto; Hiroki Mori; Koji Sugimoto; Yu Saito; Shinichiro Yamada; Michihito Asanoma

This study examined the efficacy of enteral nutrition containing hydrolyzed whey peptide (HWP) on warm ischemia/reperfusion (I/R) injury in the rat liver.


Hepato-gastroenterology | 2012

Thymidylate synthase (TS) protein expression as a prognostic factor in advanced colorectal cancer: a comparison with TS mRNA expression.

Tateo Nakagawa; Mitsuo Shimada; Nobuhiro Kurita; Takashi Iwata; Masanori Nishioka; Kozo Yoshikawa; Jun Higashijima; Toru Utsunomiya

BACKGROUND/AIMS The role of intratumoral thymidylate synthase (TS) mRNA or protein expression is still controversial and little has been reported regarding relation of them in colorectal cancer. METHODOLOGY Forty-six patients with advanced colorectal cancer who underwent surgical resection were included. TS mRNA expression was determined by the Danenberg tumor profile method based on laser-captured micro-dissection of the tumor cells. TS protein expression was evaluated using immunohistochemical staining. RESULTS TS mRNA expression tended to relate TS protein expression. Statistical significance was not found in overall survival between the TS mRNA high group and low group regardless of performing adjuvant chemotherapy. The overall survival in the TS protein negative group was significantly higher than that in positive group in all and the patients without adjuvant chemotherapy. Multivariate analysis showed TS protein expression was as an independent prognostic factor. CONCLUSIONS TS protein expression tends to be related TS mRNA expression and is an independent prognostic factor in advanced colorectal cancer.


The Journal of Medical Investigation | 2015

Clinical role of Foxp3+ regulatory T cell in Living donor related liver transplantation for prediction of life-threatening complications.

Michihito Asanoma; Hiroki Mori; Tetsuya Ikemoto; Toru Utsunomiya; Satoru Imura; Yuji Morine; Jun Hanaoka; Mami Kanamoto; Yu Saito; Shinichiro Yamada; Mitsuo Shimada

PURPOSES It is no doubt that regulatory T cells (Foxp3(+)CD4(+)CD25(+)T cells: Treg) play important roles in transplant immunity. We investigated the significance of Treg expression in acute stage of living donorrelated liver transplantation (LDLT) for the possibility of the sensitive marker for immunological state and homeostatic stress after liver transplantation. METHODS Peripheral blood was drawn from 5 recipients of LDLT preoperatively and on post operative 1, 4, 7, and 14 days. The peripheral blood mononuclear cells (PBMCs) were stained with CD4, CD25, Foxp3, and were analyzed with FACScan. This data was compared with clinical output of LDLT. RESULT The populations of Treg were significantly decreased in all patients on day 1 after LDLT and significantly increased in patients who had early postoperative complications compared with patients who had no complications. CONCLUSIONS The population of Treg in peripheral blood may reflect the surgical stress such as life-threatening complications after LDLT.


Journal of Clinical Oncology | 2014

Clinical impact of reflection to expression of EMT marker in intraductal papillary mucinous neoplasm.

Tetsuya Ikemoto; Mitsuo Shimada; Toru Utsunomiya; Satoru Imura; Yuji Morine; Yusuke Arakawa; Hiroki Mori; Mami Kanamoto; Shuichi Iwahashi; Yu Saito

244 Background: We have already reported that regulatory Tcells (Treg) reflects the aggressiveness of intraductal papillary mucinous neoplasms (IPMN) (Pancreas 2013), Notch signaling is related to agressiveness of IPMN (DDW 2012). Notch signaling, important pathway of expansion of Tregs, is considered to be one of the important factors which cause cancer progression especially through epithelial-mesenchymal transition (EMT). It still remains unclear whether EMT leads to pathological agressiveness in IPMN. Therefore, we evaluated that peripheral Treg reflected the expression of EMT-promoting transcriptional factors, Twist1 and Bmi1 in IPMN. Methods: The patients who received resections at out institute were enrolled in this study (from 2000 to 2012, n=35). Twist1, Bmi1 and E-cadherin protein expressions were investigated by immunohistochemistry. These protein expressions were compared to clinicopathological factors and peripheral Treg population. Results: Positive expression of Twist1 and Bmi1 was observed...


Journal of Clinical Oncology | 2013

Usefulness of peripheral regulatory T-cells induced by Notch signaling pathway-driven indoleamine 2, 3-dioxygenase positive dendritic cell as a biomarker for the decision for IPMN surgical indications.

Tetsuya Ikemoto; Mitsuo Shimada; Toru Utsunomiya; Yuji Morine; Satoru Imura; Hiroki Mori; Yusuke Arakawa; Mami Kanamoto; Shuichi Iwahashi; Shinichiro Yamada; Michihito Asanoma

181 Background: This study was performed to elucidate the expression of the Notch signaling pathway regulated by dendetric cell (DC) and their correlations to clinicopathological factors of intraductal papillary mucinous neoplasms (IPMNs) as a new biomarker for surgical indications. We already reported that regulatory T cells (Tregs) play an important role in tumor immunity (Pancreas 2006, ASCO-GI 2009), however, the whole mechanism of control of peripheral Tregs remains unclear. It is reported that Indoleamine 2, 3-dioxygenase (IDO) induces active Treg from naive CD4+Tcells through dendritic cells. Otherwise, we also reported that the Notch signaling pathway is involved in tumor growth and DC function (JI 2010). Thus we focused that Indoleamine 2,3-deoxygenase(IDO)-Treg axis driven by Notch signaling in IPMNs. Methods: Peripheral blood samples and resected specimens from 20 patients with IPMN were evaluated. All patients were pathologically diagnosed with IPMN. Resected specimens were immunohistochemical...


Hepato-gastroenterology | 2012

Successful case with hemophagocytic syndrome after living donor liver transplantation.

Satoru Imura; Mitsuo Shimada; Yu Saito; Syuichi Iwahashi; Jun Hanaoka; Hiroki Mori; Tetsuya Ikemoto; Yuji Morine; Toru Utsunomiya

Hemophagocytic syndrome (HPS) is a rare but serious complication that is associated with hypercytokinemia caused by activated T lymphocytes and macrophages in immunologically compromised patients. Living donor liver transplantation (LDLT) between adults has been performed to compensate for the shortage of available organs. There have been some reports of HPS after LDLT but its prognosis is disappointingly poor. Herein, we report a case of HPS in a 53-year-old woman who underwent LDLT using a left lobe graft. HPS was diagnosed on postoperative day 6 and successfully treated with a steroid pulse. HPS is a fatal complication in immunologically compromised patients but its early diagnosis and appropriate treatment can lead to an improved outcome.


Hepato-gastroenterology | 2012

The impact of pegylated-interferon α-2b on partial and massive hepatectomy model in rats.

Hiroki Mori; Mitsuo Shimada; Toru Ikegami; Toru Utsunomiya; Satoru Imura; Yuji Morine; Ikemoto T; Jun Hanaoka; Syuichi Iwahashi; Yu Saito; Michihito Asanoma; Shinichiro Yamada; Hidenori Miyake

BACKGROUND/AIMS The impact of pegylated-interferon (PEG-IFN) α-2b on liver regeneration has not yet been elucidated. METHODOLOGY Rats were divided into the following four groups: 70% hepatectomy (Hx); 70% Hx+PEG-IFN; 90% Hx and 90% Hx+PEG-IFN group (n=6 each). Rats were pretreated with subcutaneous of PEGIFN α-2b (1.5 μg/kg) administration 24 hours before Hx. Samples were taken 24, 48 and 72 hours after Hx and the following parameters were investigated: blood analysis (AST, WBC, PLT); liver weight to body weight ratio (Lw/Bw ratio); survival and PCNA labeling index (LI). RESULTS In the 90% Hx model, there was no significant difference between the Hx+PEG-IFN group and the Hx alone group in blood analysis; AST after postoperative 24 hours (2511 vs. 2466 IU/L), WBC (1200 vs. 1290) and PLT (107 vs. 111 x 10⁴/mm³), in Lw/Bw ratio at postoperative 0, 24, 48, 72 hours, respectively (0.38, 0.60, 1.14, 1.69 vs. 0.37, 0.64, 1.12, 1.63), in postoperative survival (40% vs. 45%), and in PCNA LI at postoperative 0, 24, 48, 72 hours, respectively (10.4%, 16.8%, 14.6%, 12.8% vs. 10.0%, 17.1%, 15.6%, 13.7%). In the 70% Hx model, there was no significant difference between the Hx+PEG-IFN group and the Hx alone group for all parameters. CONCLUSIONS Our data demonstrated that PEG-IFN α-2b did not affect liver regeneration and the early use of PEG-IFN α-2b would cause no problems after liver transplantation using partial grafts including living donor liver transplantation.


International Journal of Clinical Oncology | 2011

Expression of thrombospondin-1 and Ski are prognostic factors in advanced gastric cancer

Toshihiro Nakao; Nobuhiro Kurita; Masato Komatsu; Kozo Yoshikawa; Takashi Iwata; Toru Utsunomiya; Mitsuo Shimada

Collaboration


Dive into the Toru Utsunomiya's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Satoru Imura

University of Tokushima

View shared research outputs
Top Co-Authors

Avatar

Yuji Morine

University of Tokushima

View shared research outputs
Top Co-Authors

Avatar

Jun Hanaoka

Shiga University of Medical Science

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hiroki Mori

University of Tokushima

View shared research outputs
Top Co-Authors

Avatar

Yu Saito

University of Tokushima

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge